5-Amino-1MQ is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
Selectively inhibits the NNMT enzyme, which normally degrades nicotinamide and prevents NAD+ synthesis. By blocking NNMT, it frees nicotinamide for NAD+ production via the salvage pathway and activates SIRT1 longevity pathways. Also stimulates AMP-activated protein kinase (AMPK) in adipocytes and myocytes, promoting mitochondrial biogenesis and fat oxidation.
How Does 5-Amino-1MQ Work in the Body?
5-Amino-1MQ (5-Amino-1-Methyl-Quinolinium) is a Small molecule NNMT inhibitor. Synthetic compound designed to inhibit nicotinamide N-methyltransferase (NNMT) and boost NAD+ synthesis through the salvage pathway.
Understanding its mechanism of action helps researchers design protocols and predict outcomes.
What Is the Primary Mechanism of 5-Amino-1MQ?
Selectively inhibits the NNMT enzyme, which normally degrades nicotinamide and prevents NAD+ synthesis. By blocking NNMT, it frees nicotinamide for NAD+ production via the salvage pathway and activates SIRT1 longevity pathways. Also stimulates AMP-activated protein kinase (AMPK) in adipocytes and myocytes, promoting mitochondrial biogenesis and fat oxidation.
This mechanism operates at the cellular level and influences downstream pathways that produce the observable effects researchers study.
What Biological Pathways Does 5-Amino-1MQ Affect?
As a Small molecule NNMT inhibitor, 5-Amino-1MQ interacts with specific receptors and signaling cascades. These pathways are responsible for the compound's effects on fat oxidation, metabolic flexibility, improved grip strength, increased endurance, reduced muscle recovery time, anti-aging effects.
The multi-pathway activity is what gives 5-Amino-1MQ its broad potential application range — each pathway contributes to different aspects of the overall effect profile.
How Quickly Does 5-Amino-1MQ's Mechanism Take Effect?
With a half-life of not established in humans, 5-Amino-1MQ begins interacting with its target receptors within minutes of administration. However, the downstream biological effects take longer to manifest — typically days to weeks depending on the application.
Standard cycles run 4-12 weeks because that's the timeframe needed for the mechanism to produce measurable, cumulative results.
What Does the Research Say?
Improved grip strength by ~60% when combined with exercise in aged mice. Increased endurance and reduced recovery time in animal models. Preclinical evidence shows protection against diet-induced weight gain. No human clinical trials completed.
First-in-class NNMT inhibitor — the only compound that boosts NAD+ by preventing its precursor from being degraded, rather than simply supplementing more precursor.
Bottom Line on 5-Amino-1MQ's Mechanism
5-Amino-1MQ works through small molecule nnmt inhibitor activity to influence fat oxidation, metabolic flexibility, improved grip strength, increased endurance, reduced muscle recovery time, anti-aging effects. Its mechanism involves multiple pathways, which is why it shows potential across several research applications.
See our 5-Amino-1MQ benefits guide for how this mechanism translates to practical outcomes.
Complete Guide
5-Amino-1MQ : Benefits, Dosage, Side Effects & Research
Related Reading
- 5-Amino-1MQ Dosage Guide
- 5-Amino-1MQ Benefits
- 5-Amino-1MQ Side Effects
- 5-Amino-1MQ Stacking Guide
- 5-Amino-1MQ Cycle Guide
- 5-Amino-1MQ Research
Calculate Your 5-Amino-1MQ Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for 5-Amino-1MQ.
Open Calculator →Research-Grade Sourcing
If you're going to research 5-Amino-1MQ, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is 5-Amino-1MQ?
5-Amino-1MQ (5-Amino-1-Methyl-Quinolinium) is a Small molecule NNMT inhibitor. Synthetic compound designed to inhibit nicotinamide N-methyltransferase (NNMT) and boost NAD+ synthesis through the salvage pathway. It is researched for fat oxidation, metabolic flexibility, improved grip strength, increased endurance, reduced muscle recovery time, anti-aging effects.
What is the recommended 5-Amino-1MQ dosage?
Common dosages: 150-500 mcg subcutaneous, 50-100 mg oral administered once to twice daily via subcutaneous injection or oral. Cycle length: 4-12 weeks. Half-life: not established in humans. Use our peptide calculator for exact reconstitution math.
What are the side effects of 5-Amino-1MQ?
Good tolerability in preclinical data. No major adverse events reported. Limited human safety data — long-term effects in humans unknown.
Is 5-Amino-1MQ safe?
5-Amino-1MQ has shown a preliminary safety profile in research. Not FDA-approved. Available as research chemical. Not scheduled or controlled. All research should follow appropriate safety protocols.